Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Chart does not reflect overnight price. News headlines Recursion Pharmaceuticals reported mixed Q2 results, with revenue falling to $7.67 million but a narrowing net loss. Key milestones in drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results